Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C N Patil

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Cureus|March 13, 2025
Triple-Negative, HER2/Neu, and Ki67 Markers in Breast Cancer Patients Undergoing Standard of Care Treatment in India: Real-World Evidence on Tumor Aggressiveness and Survival OutcomesPravesh Dhiman, C N Patil, Sneha Konimeni, et al.
South Asian Journal of Cancer|January 2, 2023
Is Optimal Cytoreduction Post Neoadjuvant Chemotherapy the Only Prognostic Factor in Advanced Ovarian Cancer?Pravesh Dhiman, P P Bapsy, C N Patil, et al.
Indian Journal of Otolaryngology and Head and Neck Surgery : Official Publication of the Association of Otolaryngologists of India|November 20, 2019
Peripheral T Cell Lymphoma of Parotid Gland: A Diagnostic ChallengeJ G Aishwarya, Satish Nair, C N Patil, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 27, 2026
Perioperative safety and tolerability of pressurized intraperitoneal aerosolized chemotherapy (PIPAC) with concurrent systemic therapy in the same admission as a bidirectional chemotherapy: A retrospective comparative studyS P Somashekhar, K R Ashwin, C Rohitkumar, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 9, 2020
Halving Time of BCR-ABL1 in Chronic Myeloid Leukemia: Is It Better Than Day-90 Value-A Multicenter Study From South IndiaShashidhar V Karpurmath, Arun Seshachalam, Kalaiselvi Selvaraj, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Cureus|March 13, 2025
Triple-Negative, HER2/Neu, and Ki67 Markers in Breast Cancer Patients Undergoing Standard of Care Treatment in India: Real-World Evidence on Tumor Aggressiveness and Survival OutcomesPravesh Dhiman, C N Patil, Sneha Konimeni, et al.
South Asian Journal of Cancer|January 2, 2023
Is Optimal Cytoreduction Post Neoadjuvant Chemotherapy the Only Prognostic Factor in Advanced Ovarian Cancer?Pravesh Dhiman, P P Bapsy, C N Patil, et al.
Indian Journal of Otolaryngology and Head and Neck Surgery : Official Publication of the Association of Otolaryngologists of India|November 20, 2019
Peripheral T Cell Lymphoma of Parotid Gland: A Diagnostic ChallengeJ G Aishwarya, Satish Nair, C N Patil, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 27, 2026
Perioperative safety and tolerability of pressurized intraperitoneal aerosolized chemotherapy (PIPAC) with concurrent systemic therapy in the same admission as a bidirectional chemotherapy: A retrospective comparative studyS P Somashekhar, K R Ashwin, C Rohitkumar, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 9, 2020
Halving Time of BCR-ABL1 in Chronic Myeloid Leukemia: Is It Better Than Day-90 Value-A Multicenter Study From South IndiaShashidhar V Karpurmath, Arun Seshachalam, Kalaiselvi Selvaraj, et al.
Pageof 1